Centredoc acquires the patent analytics business from IPStudies

PRESS RELEASE
Neuchâtel and Châtel-St-Denis, January 17, 2022
Centredoc acquires the patent analytics business from IPStudies

CENTREDOC and IPStudies today announced that CENTREDOC has acquired the patent analytics assets and operations from IPStudies as of Jan 1st, 2022. The transferred assets include the internationally renowned patent landscapes and patent monitoring services developed by IPStudies since 2014 on the revolutionary CRISPR genome editing technology. IPStudies customers will benefit from the latest advances in patent multi-categorization and multi-source feeds as developed by Centredoc with the breakthrough RAPID5 patent monitoring suite.

Corinne Le Buhan, CEO of IPStudies, said: “CENTREDOC has many years of experience in serving patent monitoring and business intelligence to a diversity of industries in Europe and will bring the IPStudies offering to the next level. With this transfer, we assure the sustainable growth of our patent analytics services demand, as biotech and medtech C-levels are more and more combining patent data with scientific publications and business intelligence to develop their IP strategy plans. ” Harald Jenny, CEO of CENTREDOC, said: “We are delighted to integrate the excellent patent analytics knowhow and life sciences expertise of IPStudies with a strong perspective of further growth through our latest RAPID5 tools and associated services.”

For more information:

Corinne LeBuhan, +41 79 787 57 46 Harald Jenny, +41 79 435 11 80

About CRISPR: https://www.ipstudies.ch/crispr-patent-analytics/

About RAPID5: https://www.centredoc.swiss/en/rapid/

On the patents behind CRISPR babies

Just as everyone, we heard the news on the first genetically engineered babies in mankind’s history. We took a closer look this morning into our patent data to check if there’s any published details already available. Indeed, the Chinese patent office publishes its data earlier than the other countries, sometimes as early as 3 months after the filing, so if the babies are born now, there’s a good chance that the Chinese patent data is already available.

Continue reading

IPStudies Biotech patent analytics 5th anniversary at #BIO2018

We celebrate our 5th anniversary of biotech patent analytics in 2018 – that is a bit younger than the 25th anniversary of BIO2018, but we’re joining the party in Boston!

CRISPR and more generally gene editing is on many agendas this year, and we’re taking this opportunity to release a couple of new IPStudies analytics report out of our unique, exhaustive review of CRISPR-related worldwide patent applications since mid-2014:

  • a zoom on the micro-organisms subset of the landscape;
  • a review of the IP strategy of an unexpected player which has constantly ranked in the top applicants of our landscape, besides being more specialized in the ZFN technology: Sangamo Biosciences

Continue reading

January 2018 – CRISPR update

The past six months have been very busy for IPStudies, serving our CRISPR monthly data monitoring to an increasing number of subscribers. We search, sort, analyze and classify an average of 100 new CRISPR patent families every month. We’ve also answered to a number of interviews with our latest statistical data as compiled in our August update of the 2017 CRISPR patent landscape. Here is a quick review of the past months significant updates in the CRISPR patent landscape:

Continue reading

Launch of the Swiss Patent Information User Group – CHPUIG

Press Release

SWISS PATENT INFORMATION USER GROUP

Neuchâtel, the 02.11.2017 – Patent information is a strategic resource for innovative companies all around the world. Data access, difficulties induced by Asian countries patent application increase or the need to master information processing software with increasing complexity are some of the challenges that the patent information users face.

To allow a free exchange of good practices and raise general public and major companies awareness of their profession, patent information user groups have been created in many European countries, based on the US PIUG model (Patent Information User Group).

Since such group didn’t exist in Switzerland, facing the need for a space of free exchange between professionals in a national economy relaying massively on Intellectual Property, several Swiss patent information professionals decided to create the CHPIUG – Swiss Patent Information User Group.

This association, created in September 2017, gave itself a double mission: allow professionals to meet and have free exchange about good practices and tools; present their profession to companies and general public with an emphasis on the strategic questions related to patent information. It also has the mission to allow interested professionals to train on patent information use.

The association is open to any professional interested in patent information, under the condition that his main IP operates sits in Switzerland.

For more information or to join the association: www.chpiug.ch

David Borel
CHPIUG President president@chpiug.ch

Charles Madore
CHPIUG Secretary madore@patentattorneys.ch

Will the CRISPR patent landscape soon move to a one-stop license shopping?

The past 24 hours have brought new light and significant moves in the complex CRISPR patent landscape.

First (that was in European time zone!), our CRISPR expert Fabien Palazzoli celebrated the 1000th CRISPR patent family extraction out of the worldwide published patent databases. Our next monthly update will actually feature more than 1050 classified and categorized CRISPR patent families – more than 10 times the initial set of our first landscape release back in summer 2014!

Continue reading

IP management training in Paris, November 25

Corinne Le Buhan will be teaching IP management “From IP strategy to IP operations” at next IEEPI session in Paris this Friday, November 25. This professional training will help you learn about practical IP strategies and key IP management challenges from various business environments, how to define your own organisation IP strategy and how to implement it in practice with various IP development, enforcement and commercialisation tactics.

In this one-day session, emphasis is put on practical management tools and checklists, illustrated with case studies from various industries, and a situational workshop experimentation.

A couple of seats are available as last minute registration – don’t miss yours!